-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MgQM8+VK82DqO9aNj/UM3fGCIHMKj3I49l0xZEpGnIO+BVFf4pN3TB/ujQ1yFnqV F9LfamXrvFCMv2l4U2YPUQ== 0000927016-98-000435.txt : 19980211 0000927016-98-000435.hdr.sgml : 19980211 ACCESSION NUMBER: 0000927016-98-000435 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980210 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NITINOL MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0001017259 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 954090463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-48983 FILM NUMBER: 98527968 BUSINESS ADDRESS: STREET 1: 263 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6177370930 MAIL ADDRESS: STREET 1: 263 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GORDON C LEONARD CENTRAL INDEX KEY: 0000931575 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 360 LEXINGTON AVENUE STREET 2: C/O IMMUNOTHERAPY INC CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125994455 MAIL ADDRESS: STREET 1: 360 LEXINGTON AVENUE STREET 2: C/O IMMUNOTHERAPY INC CITY: NEW YORK STATE: NY ZIP: 10017 SC 13G/A 1 SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________ SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b) and (c) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No.1)/1/ NITINOL MEDICAL TECHNOLOGIES, INC. - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, PAR VALUE $.001 PER SHARE - -------------------------------------------------------------------------------- (Title of Class of Securities) 65476T104 ---------------- (CUSIP Number) /1/ The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 6 CUSIP No. 65476T104 13G Page 2 of 6 Pages 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITITS ONLY) C. Leonard Gordon ss#______________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 268,271 shares which Mr. Gordon has the right to acquire within 60 days after December 31, 1997 6 SHARED VOTING POWER 468,304 shares 7 SOLE DISPOSITIVE POWER 268,271 shares which Mr. Gordon has the right to acquire within 60 days after December 31, 1997 8 SHARED DISPOSITIVE POWER 468,304 shares 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 736,575 shares (includes 268,271 shares which Mr. Gordon has the right to acquire within 60 days after December 31, 1997) 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* Not Applicable 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 7.3% 12 TYPE OF REPORTING PERSON* IN *SEE INSTRUCTION BEFORE FILLING OUT! CUSIP NO. 65476T104 - ------------------- Item 1(a) Name of Issuer: - --------- -------------- Nitinol Medical Technologies, Inc. Item 1(b) Address of Issuer's Principal Executive Office: - --------- ---------------------------------------------- 27 Wormwood Street Boston, MA 02210 Item 2(a) Name of Person Filing: - --------- --------------------- C. Leonard Gordon Item 2(b) Address of Principal Business Office or, if none, Residence: - --------- ----------------------------------------------------------- Immunotherapy, Inc. 360 Lexington Avenue New York, New York 10017 Item 2(c) Citizenship: - --------- ----------- United States of America Item 2(d) Title of Class of Securities: - --------- ---------------------------- Common Stock, $.001 par value per share. Item 2(e) CUSIP Number: - --------- ------------ 65476T104 Item 3 Description of Person Filing: - ------ ---------------------------- Not applicable Item 4 Ownership: - ------ --------- (a) Amount Beneficially Owned: ------------------------- 736,575 shares (includes 268,271 shares which Mr. Gordon has the right to acquire within 60 days after December 31, 1997) Page 3 of 6 CUSIP No. 65476T104 - ------------------- (b) Percent of Class: ---------------- 7.3% (c) Number of shares as to which person has: ---------------------------------------- (1) sole power to vote or to direct the vote: 268,271 shares which Mr. Gordon has the right to acquire within 60 days after December 31, 1997 (ii) shared power to vote or to direct the vote: 468,304 shares (iii) sole power to dispose or to direct the disposition of: 268,271 shares which Mr. Gordon has the right to acquire within 60 days after December 31, 1997 (iv) shared power to dispose or to direct the disposition of: 468,304 shares Item 5 Ownership of Five Percent of Less of a Class: - ------ -------------------------------------------- Not applicable. Item 6 Ownership of More than Five Percent on Behalf of Another Person: - ------ --------------------------------------------------------------- Not applicable. Item 7 Identification and Classification of the Subsidiary Which - ----- --------------------------------------------------------- Acquired the Security Being Reported on by the Parent Holding ------------------------------------------------------------- Company: ------- Not applicable. Item 8 Identification and Classification of Members of the Group: - ------ --------------------------------------------------------- Not applicable. Page 4 of 6 CUSIP No. 65476T104 - ------------------- Item 9 Notice of Dissolution of Group: - ------ ------------------------------- Not applicable. Item 10 Certification: - ------- ------------- Not applicable. Page 5 of 6 CUSIP No. 65476T104 - ------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. DATED: February 5, 1998 /s/ C. Leonard Gordon ------------------------ C.Leonard Gordon Page 6 of 6 -----END PRIVACY-ENHANCED MESSAGE-----